Robotic Assisted Radical Prostatectomy (RARP): Didactic, Video based course.

Course Director:
Thomas Ahlering

Faculty:
David Albala
Todd Morgan
Alexander Ziryanov

This course will review the management of prostate cancer via the robot-assisted radical prostatectomy (RARP). This will include a discussion of the indications for RARP, review of PSA screening guidelines, and potential for side effects such as that of urinary incontinence and erectile dysfunction. Current guideline recommendations and recent evidence for pelvic lymph node dissections will also be discussed in conjunction with a step-by-step review of surgical technique and post-operative patient care. Emphasis will be placed on both oncologic and functional outcomes.

Learning Objectives:

  • Counsel patients with localized prostate cancer on appropriate treatment options, including radical prostatectomy, active surveillance, and radiation therapy.
  • Review recent literature and recommendations for pelvic lymph node dissections and PSA screening.
  • Consider possible side effects such as that of urinary incontinence and erectile dysfunction, and explore post-operative patient management.
  • Manage complex patients (i.e. patients with prior hormonal therapy, large prostates, or prior abdominal surgery)
  • Stress the importance of proactive patient follow-up, complication management, and metrics to predict patient recovery.

Agenda:

Lectures Speaker & panel
  • Welcoming and Introductions
Thomas Ahlering
  • Prostate Cancer Screening and Indications for RARP
Thomas Ahlering
  • Preoperative Evaluation and the Role of Pelvic Lymph Node Dissections
Thomas Ahlering
  • Step-by-step surgical technique of the RARP
Thomas Ahlering
David Albala
  • Bladder Neck Repair and Maximization of the Membranous Urethra
Todd Morgan
  • Postoperative Follow-up: Urinary Continence and Sexual Function
David Albala
  • Challenging Cases
Alexander Ziryanov
  • Intraoperative and Postoperative Complications and Management
David Albala
  • Open Session
Faculty
  • Adjourn

 

back to top